Anti-Aging Drugs Market to Post 8.06% CAGR to 2021, Forecasts Infiniti Research in Its Discounted Research Study Available at MarketPublishers.com
07 Dec 2017 • by Natalie Aster
LONDON – Over 2017-2021, the world’s market for anti-aging drugs is poised to grow at a healthy 8.06% CAGR. The market is being driven by the growing levels of disposable personal income and a hike in spending on healthcare in developing economies. The market has also seen the rise of various technological advances. However, the market growth is hindered by side effects associated with the use of facial aesthetic products.
Galderma, Allergan, Sanofi, and Merz Pharma, amid others, are the leading companies in the worldwide anti-aging drugs market. Other prominent vendors comprise Canbex Therapeutics, Daewoong Pharmaceutical, Revitacare, MMJ PhytoTech, SciVision Biotech, Suneva Medical, Sun Pharmaceuticals, Valeant Pharmaceuticals, and Syneron.
Discounted research study “Global Anti-aging Drugs Market 2017-2021” elaborated by Infiniti Research offers an up-close, comprehensive overview of the present-day market performance and gives insights into the growth prospects of the market globally. The report provides an analysis of the sales of different drugs in the market, thus providing estimates of the market size; gives an all-round overview of the market structure; and analyses the growth rates of the market and its segments. It provides detailed market segmentation by RoA, and region-wise. The study casts light on major market growth drivers, challenges, and trends. The research publication canvasses the competitive scenario and discusses the leading vendors operating in this marketplace. Additionally, the report provides exhaustive forecasts of the anti-aging drugs market through to 2021.
Note that this report is available at a discounted price until December 31, 2017!
To find a full collection of the publisher’s research reports, visit Infiniti Research online page at MarketPublishers.com.